Adolescents: A Prospective Single Arm Open Label Trial to Confirm Safety and Effectiveness of Prism as an Adjunct to Standard of Care in Adolescents with Post-Traumatic Stress Disorder (PTSD)
Brief description of study
The purpose of this research study is to is to establish if the FDA-approved Prism device, currently used for treating adult PTSD patients can also be safely used to help adolescents.
For more information, please email TeenPTSDTxStudy@nyulangone.org.
Clinical Study Identifier: s24-01257
ClinicalTrials.gov Identifier: NCT06854328
Principal Investigator:
Richard Gallagher.
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.